Molecular Formula | C20H25N3O3 |
Molar Mass | 355.43 |
Density | 1.267 |
Melting Point | >199°C (dec.) |
Boling Point | 625.0±55.0 °C(Predicted) |
Flash Point | 331.775 °C |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | Pale Beige |
pKa | 3.25±0.20(Predicted) |
Storage Condition | 2-8°C |
Use | This product is for scientific research only and shall not be used for other purposes. |
Overview | 5, 6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2(1H)-pyridone is one of the apixaban impurities. Apixaban (Apixaban) is an oral selective activation factor X inhibitor, jointly developed by Pfizer and Bristol-Myers Squibb. In January 2013, it obtained the import drug license issued by the State Food and Drug Administration of China, and was officially listed in China in April 2013. |
Use | 5, 6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2(1H)-pyridone is a useful research chemical. 5, 6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl) phenyl]-2(1H)-pyridone is an intermediate for the preparation of apixaban. |
Preparation method | Literature method Preparation of 1-(4-methoxyphenyl)-6-(4-aminophenyl)-7-oxo -4,5,6, 7-tetrahydro-1H-pyrazole [3,4-c] pyridine -3-ethyl acetate, a large amount of iron mud will be produced by iron powder reduction, the pollution is serious and it is not suitable to enlarge the production. |